A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects
Clinical trial NCT03020745 · COMPLETED
Trial details
- NCT number
- NCT03020745
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2019-01-28
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.